Wolverine Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Wolverine Trading’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-42,600	Closed	-$145K	–	5874
2018 Q3	$145K	Sell	42,600 -66,400	-61%	-$239K	﹤0.01%	4403
2018 Q2	$446K	Hold	109,000	–	–	﹤0.01%	3222
2018 Q1	$446K	Sell	109,000 -70,900	-39%	-$330K	﹤0.01%	3222
2017 Q4	$837K	Buy	179,900 +114,400	+175%	+$630K	﹤0.01%	2415
2017 Q3	$465K	Sell	65,500 -24,700	-27%	-$178K	﹤0.01%	2693
2017 Q2	$635K	Sell	90,200 -11,300	-11%	-$70.6K	﹤0.01%	2198
2017 Q1	$619K	Buy	+101,500	New	+$556K	﹤0.01%	2162
2016 Q4	–	Sell	-92,500	Closed	-$476K	–	5570
2016 Q3	$476K	Buy	92,500 +14,800	+19%	+$79.8K	﹤0.01%	2629
2016 Q2	$525K	Buy	+77,700	New	+$434K	﹤0.01%	2182

Wolverine Trading's KERX Position: Q4 2018 in Review

Wolverine Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 21,732 shares — an estimated $74K sold.

Wolverine Trading first reported a position in KERX in Q2 2016 and held it in 5 quarters. The position peaked at $865K in Q2 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Wolverine Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Wolverine Trading sold 21,732 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $74K.
Wolverine Trading first reported a position in Keryx Biopharmaceuticals Inc in Q2 2016 and held it in 5 quarters.
Wolverine Trading's Keryx Biopharmaceuticals Inc position peaked at $865K in Q2 2016.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Wolverine Trading's 13F filing for Q4 2018, filed 14 Feb 2019.